Dainippon To Acquire Sepracor For $2.6B

Law360, New York (September 3, 2009, 5:55 PM EDT) -- Dainippon Sumitomo Pharma Co. Ltd. said Thursday that it would acquire Sepracor Inc. for $2.6 billion, in a move that will boost the Japanese company's U.S. presence and expand its pharmaceutical portfolio to include such drugs as the blockbuster anti-insomnia pill Lunesta.

Dainippon will pay $23 per share as part of a cash tender offer, which will be followed by a merger to acquire the remaining shares at that rate, according to the drugmaker.

The deal was approved unanimously by the boards of directors of both...
To view the full article, register now.